浅析公共健康危机下的药品专利强制许可

By | 2020年6月30日

李昶郴

http://doi.org/10.6914/TPSS.202006_2(2).0005

摘要 面对新冠疫情,药品专利强制许可制度的实施是目前急需解决的问题之一。目前我国已确立了较为完备的专利强制许可制度,但该制度在我国仍呈现“零实施”的现状。我国应当借鉴域外经验,通过有条件的放开申请主体范围,提高专利许可费标准等措施完善我国药品专利强制许可的制度设计;在政策层面优先采用谈判方式弱化实施专利强制许可带来的贸易摩擦,平衡药品专利创新激励机制,积极推动药品专利强制许可制度在我国的落地实施。

关键词  药品专利  强制许可  专利政策

A Brief analysis of compulsory license of drug patent under public Health Crisis

Li Changchen

Abstract: In the face of the new crown epidemic, the implementation of the drug patent compulsory licensing system is one of the problems that needs to be solved urgently. At present, my country has established a relatively complete patent compulsory licensing system, but the system still presents a “zero implementation” status in my country. my country should learn from foreign experience, improve the system design of my country’s pharmaceutical patent compulsory licensing by conditionally liberalizing the scope of application subjects, raising patent license fees and other measures; at the policy level, preferentially adopt negotiation methods to weaken the trade frictions caused by the implementation of patent compulsory licensing , To balance the incentive mechanism for pharmaceutical patent innovation, and actively promote the implementation of the pharmaceutical patent compulsory licensing system in my country.

Key words: drug patents; compulsory license; patent policy

发表评论